DK3116897T3 - Polymyxinderivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika - Google Patents
Polymyxinderivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika Download PDFInfo
- Publication number
- DK3116897T3 DK3116897T3 DK15715172.1T DK15715172T DK3116897T3 DK 3116897 T3 DK3116897 T3 DK 3116897T3 DK 15715172 T DK15715172 T DK 15715172T DK 3116897 T3 DK3116897 T3 DK 3116897T3
- Authority
- DK
- Denmark
- Prior art keywords
- combination therapy
- various antibiotics
- polymyxin derivatives
- polymyxin
- derivatives
- Prior art date
Links
- 108010040201 Polymyxins Proteins 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201404301A GB201404301D0 (en) | 2014-03-11 | 2014-03-11 | Compounds and combinations |
| GB201421019A GB201421019D0 (en) | 2014-11-26 | 2014-11-26 | Compounds |
| PCT/EP2015/055046 WO2015135976A1 (en) | 2014-03-11 | 2015-03-11 | Polymyxin derivatives and their use in combination therapy together with different antibiotics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3116897T3 true DK3116897T3 (da) | 2022-03-28 |
Family
ID=52823596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15715172.1T DK3116897T3 (da) | 2014-03-11 | 2015-03-11 | Polymyxinderivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20170073373A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3116897B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6785659B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20160135739A (cg-RX-API-DMAC7.html) |
| CN (1) | CN106232617B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015228898B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2940455C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1125175T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3116897T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2910072T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20220387T1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL247243B (cg-RX-API-DMAC7.html) |
| LT (1) | LT3116897T (cg-RX-API-DMAC7.html) |
| MX (1) | MX359104B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3116897T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3116897T (cg-RX-API-DMAC7.html) |
| RS (1) | RS63138B1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2740190C2 (cg-RX-API-DMAC7.html) |
| SI (1) | SI3116897T1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI709575B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015135976A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2855916A1 (en) * | 2011-11-18 | 2013-05-23 | Novacta Biosystems Limited | Polymyxin derivatives |
| EP3126376B1 (en) | 2014-04-01 | 2024-08-21 | Monash University | Polymyxin derivatives as antimicrobial compounds |
| CN107108699A (zh) | 2014-11-26 | 2017-08-29 | 新药物许可控股有限公司 | 化合物 |
| EP3233889B1 (en) | 2014-12-16 | 2022-07-06 | Shanghai MicuRx Pharmaceutical Co., Ltd. | Antimicrobial polymyxins for treatment of bacterial infections |
| CN105030744B (zh) * | 2015-07-09 | 2019-04-19 | 广州英赛特生物技术有限公司 | 取代苯胍衍生物作为多粘菌素类抗生素增效剂的应用 |
| CN108350034B (zh) * | 2015-09-29 | 2022-03-11 | 莫纳什大学 | 抗微生物的多黏菌素衍生的化合物 |
| JP6744622B2 (ja) * | 2016-06-16 | 2020-08-19 | 学校法人上智学院 | ピペリジン化合物の製造方法 |
| JP2021501783A (ja) * | 2017-11-02 | 2021-01-21 | ザ ユニバーシティー オブ クイーンズランド | ペプチド抗生物質 |
| LT3810633T (lt) | 2018-06-25 | 2024-01-10 | Spero Therapeutics, Inc. | Junginiai |
| CN111690040A (zh) * | 2019-03-12 | 2020-09-22 | 上海来益生物药物研究开发中心有限责任公司 | 多粘菌素衍生物、其制备方法和应用 |
| CN115298198A (zh) | 2020-01-21 | 2022-11-04 | 上海盟科药业股份有限公司 | 用于肾相关癌症靶向治疗的新型化合物和组合物 |
| TW202233649A (zh) | 2020-11-06 | 2022-09-01 | 美商斯佩羅治療學股份有限公司 | 化合物 |
| CN120699105B (zh) * | 2025-08-19 | 2025-11-21 | 中国药科大学 | 一种氘代抗菌肽及其组合物和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060004185A1 (en) * | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| SI2057185T1 (sl) * | 2006-08-11 | 2016-10-28 | Northern Antibiotics Oy | Derivati polimiksina in njihove uporabe |
| WO2010075416A1 (en) * | 2008-12-23 | 2010-07-01 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| CN101851270A (zh) * | 2009-04-03 | 2010-10-06 | 梁浩 | 一种多粘菌素衍生物及其制备方法 |
| US8415307B1 (en) * | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| WO2012168820A1 (en) * | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| CA2855916A1 (en) * | 2011-11-18 | 2013-05-23 | Novacta Biosystems Limited | Polymyxin derivatives |
| PT2999711T (pt) * | 2013-05-22 | 2022-07-29 | Spero Therapeutics Inc | Derivados de polimixina e a sua utilização em terapia de combinação em conjunto com antibióticos diferentes |
-
2015
- 2015-03-11 US US15/125,415 patent/US20170073373A1/en not_active Abandoned
- 2015-03-11 CN CN201580011858.0A patent/CN106232617B/zh active Active
- 2015-03-11 RS RS20220387A patent/RS63138B1/sr unknown
- 2015-03-11 AU AU2015228898A patent/AU2015228898B2/en active Active
- 2015-03-11 RU RU2016139978A patent/RU2740190C2/ru active
- 2015-03-11 WO PCT/EP2015/055046 patent/WO2015135976A1/en not_active Ceased
- 2015-03-11 KR KR1020167027152A patent/KR20160135739A/ko not_active Ceased
- 2015-03-11 MX MX2016011682A patent/MX359104B/es active IP Right Grant
- 2015-03-11 PT PT157151721T patent/PT3116897T/pt unknown
- 2015-03-11 PL PL15715172T patent/PL3116897T3/pl unknown
- 2015-03-11 CA CA2940455A patent/CA2940455C/en active Active
- 2015-03-11 LT LTEPPCT/EP2015/055046T patent/LT3116897T/lt unknown
- 2015-03-11 ES ES15715172T patent/ES2910072T3/es active Active
- 2015-03-11 SI SI201531832T patent/SI3116897T1/sl unknown
- 2015-03-11 KR KR1020237036093A patent/KR20230152779A/ko active Pending
- 2015-03-11 TW TW104107773A patent/TWI709575B/zh active
- 2015-03-11 HR HRP20220387TT patent/HRP20220387T1/hr unknown
- 2015-03-11 JP JP2016556784A patent/JP6785659B2/ja active Active
- 2015-03-11 DK DK15715172.1T patent/DK3116897T3/da active
- 2015-03-11 EP EP15715172.1A patent/EP3116897B1/en active Active
-
2016
- 2016-08-11 IL IL247243A patent/IL247243B/en active IP Right Grant
-
2021
- 2021-01-25 US US17/157,393 patent/US20210221848A1/en not_active Abandoned
-
2022
- 2022-04-20 CY CY20221100299T patent/CY1125175T1/el unknown
-
2023
- 2023-03-24 US US18/126,270 patent/US20230322858A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20250034I1 (fi) | O-deuteroitu atropiini ja erityisesti O-deuteroidun atropiinin deuterohemisulfaattisuola | |
| FIC20230014I1 (fi) | Foslevodopa ja foskarbidopa | |
| DK2999711T3 (da) | Polymyxin-derivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika | |
| DK3116897T3 (da) | Polymyxinderivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika | |
| DK3256218T3 (da) | Kdm1a-hæmmer og anvendelse deraf i terapi | |
| DK3235830T3 (da) | Interleukin-15-proteinkompleks og anvendelse deraf | |
| SI3328419T1 (sl) | PD-1-vezavne molekule in postopki uporabe le-teh | |
| DK3169704T3 (da) | Molekyler med specificitet for cd45 og cd79 | |
| DK3149001T3 (da) | Hidtil ukendte pyrazolopyrimidinderivater og deres anvendelse som MALT1-hæmmere | |
| EP3164406C0 (en) | BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USES | |
| SI3179991T1 (sl) | Terapevtske kombinacije zaviralca BTK in zaviralca BCL-2 | |
| LT3331877T (lt) | Pirazolpirimidino dariniai ir jų panaudojimas | |
| HRP20181742T1 (hr) | Hidroksialkil-supstituirani derivati feniltriazola i njihova uporaba | |
| IL252560A0 (en) | Heterocyclic derivatives and their uses | |
| DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
| EP3334429C0 (en) | HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR | |
| DK3065759T3 (da) | Immunosuppressive midler og deres anvendelse i terapi | |
| HRP20182134T1 (hr) | Triazinski spoj i njegova upotreba u medicinske svrhe | |
| SI3290441T1 (sl) | RGMA-vezavni protein in njegova uporaba | |
| KR20180084747A (ko) | Galgt2 유전자 치료 방법 및 물질 | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| HUE058314T2 (hu) | Pridopidin alkalmazása Rett-szindróma kezelésére | |
| EP3193805A4 (en) | DUAL CONFIGURATION PORTABLE WHEELCHAIR | |
| HUE045025T2 (hu) | Heterobiciklusos vegyületek és alkalmazásuk tuberkulózis kezelésére | |
| DK3208332T3 (da) | Laktaseopløsning og mælk med samme |